- TWD10.59bn
- TWD13.83bn
- TWD19.81bn
- 57
- 62
- 57
- 65
2019 December 31st | C2020 December 31st | C2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 12,307 | 14,279 | 12,001 | 17,311 | 19,814 |
Cost of Revenue | |||||
Gross Profit | 1,251 | 1,724 | 1,569 | 2,224 | 2,780 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 11,839 | 13,608 | 11,484 | 16,988 | 19,328 |
Operating Profit | 468 | 671 | 517 | 323 | 485 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 517 | 718 | 714 | 428 | 708 |
Provision for Income Taxes | |||||
Net Income After Taxes | 415 | 564 | 605 | 352 | 578 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 379 | 549 | 578 | 413 | 592 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 379 | 549 | 578 | 413 | 592 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.53 | 2.89 | 2.52 | 2.17 | 3.13 |
Dividends per Share |